NCI COVID-19 in Cancer Patients, NCCAPS Study

Major Program
NCI Community Oncology Research Program
Research Group
Community Oncology and Prevention Trials
Sponsor
National Cancer Institute (NCI)
Status
Active, not recruiting
ClinicalTrials.gov ID
For more information, see ClinicalTrials.gov NCT04387656
This study collects blood samples, medical information, and medical images from patients who
are being treated for cancer and have a positive test for SARS CoV-2, the new coronavirus
that causes the disease called COVID-19. Collecting blood samples, medical information, and
medical images may help researchers determine how COVID-19 affects the outcomes of patients
undergoing cancer treatment and how having cancer affects COVID-19.
Intervention
Biospecimen Collection, Data Collection, Quality-of-Life Assessment, Questionnaire Administration
Condition
COVID-19 Infection, Hematopoietic and Lymphoid System Neoplasm, Malignant Solid Neoplasm, Metastatic Malignant Solid Neoplasm
Investigators
Larissa A Korde

See list of participating sites